Literature DB >> 24009149

Can stroma reaction predict cancer lethality?

Michael R Freeman1, Quanlin Li, Leland W K Chung.   

Abstract

Stromal features in carcinomas may provide a relatively consistent means to stratify patients afflicted with solid tumors. Stroma-derived transcriptome signatures can now be used to make predictions about patient survival, suggesting the potential for their clinical application in precision medicine to predict disease progression and emergence of therapeutic resistance. ©2013 AACR.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24009149      PMCID： PMC3983789          DOI： 10.1158/1078-0432.CCR-13-1694

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

1.  Stromal responses among common carcinomas correlated with clinicopathologic features.

Authors:  Julia L-Y Chen; Iñigo Espinosa; Albert Y Lin; Olivia Y-W Liao; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2013-06-26       Impact factor: 12.531

2.  Tissue interactions and prostatic growth: II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetal urogenital sinus implants.

Authors:  G J Miller; M N Runner; L W Chung
Journal:  Prostate       Date:  1985       Impact factor: 4.104

3.  Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.

Authors:  Christine Desmedt; Samira Majjaj; Naima Kheddoumi; Sandeep K Singhal; Benjamin Haibe-Kains; Frank El Ouriaghli; Carole Chaboteaux; Stefan Michiels; Françoise Lallemand; Fabrice Journe; Hughes Duvillier; Sherene Loi; John Quackenbush; Sophie Dekoninck; Cédric Blanpain; Laurence Lagneaux; Nawal Houhou; Mauro Delorenzi; Denis Larsimont; Martine Piccart; Christos Sotiriou
Journal:  Clin Cancer Res       Date:  2012-01-10       Impact factor: 12.531

4.  Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.

Authors:  S Feng; F Wang; A Matsubara; M Kan; W L McKeehan
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

5.  Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

Authors:  Shian-Ying Sung; Chia-Ling Hsieh; Andrew Law; Haiyen E Zhau; Sen Pathak; Asha S Multani; Sharon Lim; Ilsa M Coleman; Li-Chin Wu; William D Figg; William L Dahut; Peter Nelson; Jae K Lee; Mahul B Amin; Robert Lyles; Peter A J Johnstone; Fray F Marshall; Leland W K Chung
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

6.  The fibromatosis signature defines a robust stromal response in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; C Blake Gilks; Matt van de Rijn; Robert B West
Journal:  Lab Invest       Date:  2008-04-14       Impact factor: 5.662

7.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis.

Authors:  Y Inaguma; M Kusakabe; E J Mackie; C A Pearson; R Chiquet-Ehrismann; T Sakakura
Journal:  Dev Biol       Date:  1988-08       Impact factor: 3.582

8.  Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.

Authors:  Gustavo Ayala; Jennifer A Tuxhorn; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Makoto Ohori; Marcus Wheeler; Jeffrey Spitler; David R Rowley
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

9.  Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.

Authors:  Peizhen Hu; Gina C-Y Chu; Guodong Zhu; Hua Yang; Daniel Luthringer; Gail Prins; Fouad Habib; Yuzhuo Wang; Ruoxiang Wang; Leland W K Chung; Haiyen E Zhau
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  Determination of stromal signatures in breast carcinoma.

Authors:  Robert B West; Dimitry S A Nuyten; Subbaya Subramanian; Torsten O Nielsen; Christopher L Corless; Brian P Rubin; Kelli Montgomery; Shirley Zhu; Rajiv Patel; Tina Hernandez-Boussard; John R Goldblum; Patrick O Brown; Marc van de Vijver; Matt van de Rijn
Journal:  PLoS Biol       Date:  2005-05-10       Impact factor: 8.029
View more
  10 in total

1.  The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.

Authors:  J H Park; C H Richards; D C McMillan; P G Horgan; C S D Roxburgh
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

2.  RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation.

Authors:  Woosook Kim; David A Barron; Rebeca San Martin; Keith S Chan; Linda L Tran; Feng Yang; Steven J Ressler; David R Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis.

Authors:  Kan He; Wenwen Lv; Dongni Zheng; Fei Cheng; Tao Zhou; Shoudong Ye; Qian Ban; Qilong Ying; Bei Huang; Lei Chen; Guohua Wu; Dahai Liu
Journal:  Oncotarget       Date:  2015-04-20

Review 4.  Profiling Prostate Cancer Therapeutic Resistance.

Authors:  Cameron A Wade; Natasha Kyprianou
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

5.  Tumor proportion in colon cancer: results from a semiautomatic image analysis approach.

Authors:  Benedikt Martin; Bettina Monika Banner; Eva-Maria Schäfer; Patrick Mayr; Matthias Anthuber; Gerhard Schenkirsch; Bruno Märkl
Journal:  Virchows Arch       Date:  2020-02-19       Impact factor: 4.064

6.  Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.

Authors:  Jun Jiang; Burak Tekin; Lin Yuan; Sebastian Armasu; Stacey J Winham; Ellen L Goode; Hongfang Liu; Yajue Huang; Ruifeng Guo; Chen Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-07

7.  The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.

Authors:  F J A Gujam; D C McMillan; Z M A Mohammed; J Edwards; J J Going
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

8.  Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.

Authors:  Zheng Cao; Shahriar Koochekpour; Stephen E Strup; Natasha Kyprianou
Journal:  Oncotarget       Date:  2017-07-28

9.  An isoform of AIF1 involved in breast cancer.

Authors:  Ferial Amira Slim; Geneviève Ouellette; Kaoutar Ennour-Idrissi; Simon Jacob; Caroline Diorio; Francine Durocher
Journal:  Cancer Cell Int       Date:  2018-10-22       Impact factor: 5.722

10.  Association of the tumour stroma percentage in the preoperative biopsies with lymph node metastasis in colorectal cancer.

Authors:  Meiting Fu; Dexin Chen; Fuzheng Luo; Mengshu Li; Yadong Wang; Junsheng Chen; Aimin Li; Side Liu
Journal:  Br J Cancer       Date:  2019-12-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.